Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides

This study is currently recruiting participants.

Study NCT00074087 Information provided by National Cancer Institute (NCI)

First Received: December 10, 2003 Last Updated: July 23, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given